Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
Create a narrative
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
59.6% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
25
users have liked this narrative
7
users have commented on this narrative
56
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.9% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
31
users have liked this narrative
6
users have commented on this narrative
88
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.8% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Systemair
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Expansion Into India And Sustainability Initiatives Will Strengthen Future Competitiveness
Key Takeaways Strategic M&A activity and facility expansions position Systemair for potential revenue growth through market expansion and enhanced production capacity. Focus on sustainability and new refrigerants strengthens Systemair’s competitive edge, supporting revenue growth through improved product offerings.
View narrative
SEK 95.33
FV
1.3% overvalued
intrinsic discount
2.90%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
about 12 hours ago
author updated this narrative
Befesa
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Decarbonization And Circular Economy Will Expand Recycling Demand
Key Takeaways Growth driven by global decarbonization trends, regulatory pressures, and expansion into US and Chinese markets, positioning Befesa for higher volumes and improved margins. Strong zinc hedging, process efficiencies, and long-term contracts enhance margin stability, recurring revenues, and cash flow resilience despite market fluctuations.
View narrative
€35.44
FV
26.2% undervalued
intrinsic discount
5.93%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
about 12 hours ago
author updated this narrative
Luxfer Holdings
AN
AnalystConsensusTarget
Consensus Narrative from 1 Analyst
Decarbonization And Hydrogen Energy Will Boost High-Performance Material Markets
Key Takeaways Rising demand for decarbonization and advanced materials strengthens Luxfer's position in premium sectors, supporting growth and profitability. Efficiency initiatives and focusing on higher-value sectors enhance margin expansion, resilience, and long-term earnings potential.
View narrative
US$17.00
FV
29.4% undervalued
intrinsic discount
0.73%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 12 hours ago
author updated this narrative
Zydus Wellness
AN
AnalystConsensusTarget
Consensus Narrative from 6 Analysts
Expanding Health Markets And Digital Channels Will Build Long-Term Value
Key Takeaways Expansion into high-growth wellness categories and strong brand equity are driving resilient revenue streams and supporting premium pricing power. Digital transformation and improved distribution are enhancing margin potential, while input cost stabilization aids further profitability gains.
View narrative
₹2.38k
FV
18.6% undervalued
intrinsic discount
10.21%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
technotrans
AN
AnalystConsensusTarget
Consensus Narrative from 3 Analysts
Sustainable Cooling And Energy Management Will Strengthen Future Position
Key Takeaways technotrans' focus on sustainability and energy efficiency, particularly in cooling systems, positions it for future revenue growth amid rising demand for sustainable products. Investments in energy management and data center cooling solutions, coupled with restructuring efforts, are expected to enhance revenue, margins, and operational efficiency.
View narrative
€27.00
FV
13.7% undervalued
intrinsic discount
6.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
about 12 hours ago
author updated this narrative
Rossari Biotech
AN
AnalystConsensusTarget
Consensus Narrative from 4 Analysts
Capacity Expansions And Green Chemistry Will Unlock Southeast Asia Markets
Key Takeaways Capacity expansions, overseas investments, and integration of acquisitions are set to boost revenue growth, operating leverage, and strengthen earnings resilience through diversification. Ongoing R&D in green chemistry and expansion into premium, eco-friendly segments will help capture new markets, support margin growth, and align with global sustainability trends.
View narrative
₹870.00
FV
25.5% undervalued
intrinsic discount
16.56%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
about 12 hours ago
author updated this narrative
Lojas Renner
AN
AnalystConsensusTarget
Consensus Narrative from 14 Analysts
Advanced AI And Technology Will Improve Future Performance
Key Takeaways Completion of investment cycles and technological advancements enhance profitability and boost revenue through improved fashion execution, trend identification, and inventory management. Store and digital expansion in underpenetrated areas, along with new distribution centers, drive revenue growth, market share gains, and improved e-commerce performance.
View narrative
R$20.52
FV
12.1% undervalued
intrinsic discount
8.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
10
users have followed this narrative
about 12 hours ago
author updated this narrative
Taaleri Oyj
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Joensuu Biomass And Hamina Biorefinery Will Evolve Amid Risks
Key Takeaways Expansion in bioindustry and biorefinery operations could boost revenues and net margins through increased production and new client acquisitions. Strategic real estate partnerships and successful fundraising in renewable energy investments suggest potential for increased revenue growth and net margins.
View narrative
€9.10
FV
23.1% undervalued
intrinsic discount
0.60%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
about 12 hours ago
author updated this narrative
Genus
AN
AnalystConsensusTarget
Consensus Narrative from 8 Analysts
FDA Approval Of PRP Program In 2025 Will Open Significant Revenue Stream
Key Takeaways Growth in the porcine division and strategic partnerships in China are expected to enhance Genus's revenue and earnings. Expansion in the bovine segment through acquisitions and programs like VAP is projected to improve profit margins and financial stability.
View narrative
UK£26.59
FV
5.8% undervalued
intrinsic discount
4.58%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
about 12 hours ago
author updated this narrative
Value any company in seconds
Popular companies